TELMISARTAN HCTZ JL 40/12.5 telmisartan/hydrochlorothiazide 40/12.5 mg tablets blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

hydrochlorothiazide, Quantity: 12.5 mg; telmisartan, Quantity: 40 mg iodine/mL

Available from:

Arrotex Pharmaceuticals Pty Ltd

Pharmaceutical form:

Tablet, multilayer

Composition:

Excipient Ingredients: sodium starch glycollate type A; mannitol; povidone; magnesium stearate; meglumine; sodium hydroxide; iron oxide red

Administration route:

Oral

Units in package:

30 tablets, 28 tablets, 56 tablets, 14 tablets, 98 tablets

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Telmisartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension. Treatment should not be initiated with these combinations.

Product summary:

Visual Identification: Tablets are red and white oval shaped two-layer tablets. The white face is marked with C31.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Registered

Authorization date:

2019-03-14